Subscribe

Interference with aPTT-Based Assays By Emicizumab

Specialty:

Clinical Laboratory
Hematology Oncology

Objective:

ICD-10:

Description:

Emicizumab is a bispecific antibody that targets Factors IXa and X. It mimics Factor VIIIa cofactor activity and is used for prophylaxis in patients with hemophilia A. Its presence can interfere with aPTT-based assays.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone